INSIGHT-Pfizer, Bristol revive cancer drugs that rev up immune system

NEW YORK, Aug 7 (Reuters) - Some of the most heralded new cancer drugs fight the disease by removing brakes on the immune system. Now a few leading drugmakers are paying attention to a second, opposing force: medicines that accelerate the immune system's attack.